Vantive: A New Company Built On Our Legacy Baxter is on a journey to spin off our ~$5B Kidney Care segment into a standalone company. Vantive will build on our nearly 70-year legacy in acute therapies and
Our work involves quantifying and controlling the risks introduced by bad actors, turning unpredictability into manageable outcomes. Here’s more of what you will get to do Risk Analysis & Solutioning : Conduct proactive risk analysis on
Vantive: A New Company Built On Our LegacyBaxter is on a journey to spin off our ~$5B Kidney Care segment into a standalone company. Vantive will build on our nearly 70-year legacy in acute therapies and home